TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

David Jackman, MD

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115
  • CLINICAL TRIALS 3
  • CONDITIONS3
  • INTERVENTIONS3
  • SINCE2008
An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma

December 2008 - March 2012
Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC

December 2009 - October 2011
Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

October 2009 - December 2012
Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Mesothelioma

Erlotinib

Hydroxychloroquine

Morab-009 Amatuximab By Iv On Days 1 And 8 Every 21 Days For 6 Cycles.

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo